President Trump Signals Openness to Medical Cannabis-MMJ BioPharma Files Emergency Motion to DEA Administrator Terry Cole

August 11, 2025 6:30 PM

MMJ BioPharma Cultivation announced today it will file an emergency motion directly to newly confirmed DEA Administrator Terrance "Terry" Cole, seeking immediate action on the company's long delayed application to grow pharmaceutical grade cannabis for FDA approved clinical trials in Huntington's disease and Multiple Sclerosis. The move comes just hours after President Donald Trump addressed the nation on marijuana rescheduling,...

Read more

Genie Healthcare Partners With and Invests in Vizzhy to Accelerate the U.S. Expansion of AI-Guided Precision Medicine and Scalable Clinical Deployment

August 11, 2025 5:00 PM

Genie Healthcare, a national leader in clinical staffing and healthcare AI integration, today announced a strategic partnership and lead investment in Vizzhy, a pioneering health intelligence company transforming chronic disease care through AI-guided precision medicine.This partnership combines Genie's deep expertise in real-world staffing operations with Vizzhy's scalable care platform, accelerating the deployment of clinically validated,...

Read more

ZetrOZ Systems' sam Wearable Ultrasound Device Offers At-Home Treatment for People with Arthritis

August 11, 2025 9:01 AM

Osteoarthritis, the most common form of arthritis, affects more than 63 million adults nationwide. The sam® wearable ultrasound unit, which recently received Ease of Use Certification from the Arthritis Foundation, allows arthritis patients to manage the painful inflammatory disease from home.The sam® device, developed and manufactured by Connecticut-based ZetrOZ Systems, is cleared by the U.S. Food and Drug Administration for the treatment of...

Read more

Hypha Labs Expands List of Functional Mushrooms Able to be Produced in its Revolutionary Mushroom Accelerator

August 11, 2025 9:00 AM

Hypha Labs, Inc. (OTCQB:FUNI), an A.I. powered pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce that the Company has expanded the array of functional mushroom ingredients that can be harvested at home in an eight day cycle using the most recent enhancements of its revolutionary device.Recent breakthroughs in the Company's R&D efforts now allow for the most potent HOME...

Read more

Aptevo Therapeutics Reports 2Q25 Financial Results And Provides A Business Update

August 11, 2025 8:05 AM

Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology Company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR® and ADAPTIR-FLEX® platform technologies, today reported financial results for the quarter ended June 30, 2025, and provided a business update.Second Quarter HighlightsPipeline Expansion - Introduced APVO455, a Nectin-4 x CD3 bispecific for solid tumors, expanding the Company's...

Read more

BODYWELLE Joins Forces With Sunset Padel for Wellness Meets Performance Event in Miami Beach

August 11, 2025 8:00 AM

BODYWELLE, a modern aesthetic and longevity clinic led by Dr. Alonso Martin, is teaming up with Sunset Padel, an elite indoor padel facility in Miami Beach, for an immersive wellness and performance event designed to introduce the community to a new standard in body care and athletic optimization. The event, titled "Strong Body, Strong Game - BODYWELLE × Sunset Padel," will take place on Thursday, August 21, from 11:30 AM to 1:30 PM at Sunset...

Read more

Amphastar Announces FDA Approval for Iron Sucrose Injection, USP

August 11, 2025 6:00 AM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH), a biopharmaceutical company focused on developing, manufacturing, and marketing complex generic and proprietary injectable, inhalation, and intranasal products, today announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's Abbreviated New Drug Application ("ANDA") for Iron Sucrose Injection, USP 50mg/2.5mL, 100mg/5mL, and 200mg/10mL in single-dose vials, previously...

Read more

Trump May Reclassify Marijuana - MMJ BioPharma To Escape The DEA's Seven Year Cannabis Trial Roadblock?

August 11, 2025 5:00 AM

President Donald J. Trump is thinking about moving marijuana to a lower drug classification, according to the Wall Street Journal and other reports. If he does, it will finally crack open the door for companies like MMJ BioPharma Cultivation- and for patients who have been waiting far too long for real, FDA-approved cannabis medicines. At a recent private fundraiser, Trump said he was looking at reclassifying marijuana from Schedule I - the...

Read more

IRLAB's CFO Viktor Siewertz Leaves the Company for a New Leading Position

August 11, 2025 3:20 AM

IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announces that Viktor Siewertz has decided to leave his position as Chief Financial Officer to take a senior position in another company. He will step down as CFO on August 31, 2025."Viktor Siewertz, has with his financial expertise, strategic insights, and strong connections to both the Swedish and international...

Read more

Relief Therapeutics Advances Publication of 2025 Half-Year Report

August 11, 2025 1:20 AM

RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced that it has advanced the publication date of its 2025 half-year report. Originally scheduled for release on August 27, 2025, the report will now be published on August 14, 2025, ahead of market opening. The...

Read more

TERRY COLE FIX IT! DEA Blocks FDA Cannabis Trials While Contaminated Marijuana Floods State Markets

August 10, 2025 5:00 AM

While patients suffering from Huntington's disease, Multiple Sclerosis, and other debilitating conditions await life saving cannabis based treatments, the U.S. Drug Enforcement Administration (DEA) continues to flaunt its profound ignorance, regulatory negligence, and outright corruption. The agency's mission claims to "ensure an adequate and uninterrupted supply of controlled substances for medical and scientific needs," but internal statements...

Read more

Unlock the Power of MK-677: Your Guide to Buying MK-677 Ibutamoren Online

August 9, 2025 9:06 PM

Are you ready to elevate your fitness and wellness? If you're seeking to boost growth hormone levels, improve body composition, and gain benefits, MK-677, also known as Ibutamoren, is a top choice. This orally active growth hormone secretagogue comes in capsule form, often in 60 capsules bottles, for easy daily use. Dive into MK-677 research or learn what you need to know about MK-677 about this white powder compound. Explore MK-677 Ibutamoren...

Read more

Top 6 Best Joint Supplements for Dogs to Support Canine Joint Health and Pain Relief

August 9, 2025 8:50 PM

Explore a wide range of top-rated joint supplements for dogs here.Nutramax Laboratories Dasuquin with MSM Soft Chews for Large Dogs - Veterinary Recommended Joint Support When it comes to veterinary medicine and canine joint health, Nutramax Laboratories Dasuquin with MSM Soft Chews stands out as the #1 veterinarian recommended joint health supplement brand. This advanced joint supplement for dogs combines glucosamine, chondroitin sulfate, and...

Read more

Buy MK-677 ibutamoren Capsules - Increase GH levels with Capsules

August 9, 2025 8:45 PM

Are you ready to elevate your fitness and wellness? If you're seeking to boost growth hormone levels, improve body composition, and gain benefits, MK-677, also known as Ibutamoren, is a top choice. This orally active growth hormone secretagogue comes in capsule form, often in 60 capsules bottles, for easy daily use. Dive into MK-677 research or learn what you need to know about MK-677 about this white powder compound. Explore MK-677 Ibutamoren...

Read more

Sleep Lean Reviews (INVESTIGATED): What We Discovered After 90 Days of Testing Sleep and Weight Loss Results

August 9, 2025 12:45 PM

When we first heard about Sleep Lean, our expectations were low. The promises were almost too good to believe - burn fat while you sleep, balance stress hormones, wake up refreshed, all without changing your diet or adding workouts. Honestly, it sounded like another overhyped gimmick. In this exclusive 2025 review, we walk you through our entire 3-month experience - the steady weight loss, deeper and more restorative sleep, and the surprising...

Read more

ProstaVive Reviews Investigated: Surprising Truths About Prostate Health Support in 2025 (Consumer Report And Side Effects)

August 9, 2025 12:30 PM

A growing buzz is forming around ProstaVive, a dietary supplement promoted as a natural way to support prostate health by addressing inflammation, hormonal shifts, and urinary discomfort at their root. Marketed as a non-pharmaceutical option with a clinically formulated blend, ProstaVive is quickly attracting attention among men seeking relief without prescription drugs or harsh side effects. Yet in a market crowded with bold claims, the...

Read more

Synoshi Pro Reviews: Don't Buy Till You've Read This! 

August 9, 2025 12:05 PM

Let's face it, cleaning the bathroom, kitchen, and other areas of the home can be a tiresome and time-consuming task and everyone of us struggles with that. No wonder so many people pay to have their homes cleaned! But paying for cleaning services every time can empty your bank account in no time! You sure do not want to go broke for something you could actually do by yourself seamlessly with this new viral cleaning tool.Many people are tired of...

Read more

BioNxt Solutions Announces Closing of Final Tranche of Oversubscribed Convertible Debenture Unit Private Placement

August 8, 2025 7:00 PM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:BNXTF)(FSE:BXT), is pleased to announce today that it has closed the final tranche of its previously announced non‐brokered private placement (the "Offering") of convertible debenture units (the "Debenture Units") at a price of $0.60 per Debenture Unit, for gross proceeds of $241,200. The $241,200 represents the principal amount outstanding pursuant to the Debentures (as defined...

Read more

CV Sciences, Inc. To Announce Second Quarter 2025 Results On August 13, 2025

August 8, 2025 5:00 PM

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced that it will release financial results for the second quarter ended June 30, 2025, after the stock market closes on Wednesday, August 13, 2025. The Company will hold a conference call with the investment community...

Read more

Dr. Sacha Obaid Named to 2025 Southlake Style Top Docs List

August 8, 2025 3:15 PM

Dr. Sacha Obaid, founder and lead surgeon of North Texas Plastic Surgery, has been named to the 2025 Southlake Style Top Docs directory. This recognition, determined through a peer-nomination process, highlights Dr. Obaid's continued dedication to delivering exceptional care and his strong reputation among fellow physicians.The Southlake Style Top Docs list is compiled annually, with local medical professionals nominating their peers based on...

Read more